Alpha 2.0
Login Register
» Articles » PMID: 8460927

In Vitro Activity of RP59500, an Injectable Streptogramin Antibiotic, Against Vancomycin-resistant Gram-positive Organisms

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1993 Mar 1
PMID 8460927
Citations 32
Authors
L A Collins
G J Malanoski
G M Eliopoulos
C B Wennersten
M J Ferraro
R C Moellering Jr
Affiliations
Soon will be listed here.
Abstract

The in vitro activity of RP59500, a streptogramin antibiotic, against 146 clinical isolates of vancomycin-resistant gram-positive bacteria was examined. Five strains of the species Enterococcus casseliflavus and Enterococcus gallinarum, for which the MIC of vancomycin was 8 micrograms/ml, were also studied. Twenty-eight vancomycin-susceptible strains of Enterococcus faecalis and Enterococcus faecium were included for comparison. The drug was highly active against Leuconostoc spp., Lactobacillus spp., and Pediococcus spp. (MICs, < or = 2 micrograms/ml). RP59500 was more active against vancomycin-susceptible strains of E. faecium than E. faecalis (MICs for 90% of the strains [MIC90s], 1.0 versus 32 micrograms/ml). Vancomycin-resistant strains of E. faecalis were as resistant to RP59500 as vancomycin-susceptible strains (MIC90, 32 micrograms/ml), but some vancomycin-resistant E. faecium strains were relatively more resistant to the new agent (MIC90, 16; MIC range, 0.5 to 32 micrograms/ml) than were vancomycin-susceptible organisms of this species.

Citing Articles

A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Cassir N, Rolain J, Brouqui P Front Microbiol. 2014; 5:551.

PMID: 25368610 PMC: 4202707. DOI: 10.3389/fmicb.2014.00551.

Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Butaye P, Devriese L, Haesebrouck F Clin Microbiol Rev. 2003; 16(2):175-88.

PMID: 12692092 PMC: 153145. DOI: 10.1128/CMR.16.2.175-188.2003.

In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model.

Allen G, Cha R, Rybak M Antimicrob Agents Chemother. 2002; 46(8):2606-12.

PMID: 12121940 PMC: 127363. DOI: 10.1128/AAC.46.8.2606-2612.2002.

Treatment options for vancomycin-resistant enterococcal infections.

Linden P Drugs. 2002; 62(3):425-41.

PMID: 11827558 DOI: 10.2165/00003495-200262030-00002.

Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.

Luh K, Hsueh P, Teng L, Pan H, Chen Y, Lu J Antimicrob Agents Chemother. 2000; 44(12):3374-80.

PMID: 11083643 PMC: 90208. DOI: 10.1128/AAC.44.12.3374-3380.2000.

References
1.
Aumercier M, Bouhallab S, Capmau M, Le Goffic F . RP 59500: a proposed mechanism for its bactericidal activity. J Antimicrob Chemother. 1992; 30 Suppl A:9-14. DOI: 10.1093/jac/30.suppl_a.9. View
2.
Maple P, Hamilton-Miller J, Brumfitt W . World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1989; 1(8637):537-40. DOI: 10.1016/s0140-6736(89)90076-7. View
3.
Courvalin P . Resistance of enterococci to glycopeptides. Antimicrob Agents Chemother. 1990; 34(12):2291-6. PMC: 172048. DOI: 10.1128/AAC.34.12.2291. View
4.
Verbist L, Verhaegen J . Comparative in-vitro activity of RP 59500. J Antimicrob Chemother. 1992; 30 Suppl A:39-44. DOI: 10.1093/jac/30.suppl_a.39. View
5.
Aldridge K, Schiro D, Varner L . In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods. Antimicrob Agents Chemother. 1992; 36(4):854-5. PMC: 189457. DOI: 10.1128/AAC.36.4.854. View